# MD Anderson decision aid for multi-cancer early detection testing

Source: https://onco.cc/trials/mdacc-mced-decision-aid/  
OnCo record `mdacc-mced-decision-aid` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A study building a guide to help people decide whether to have a multi-cancer blood test.

## Summary

MD Anderson decision aid for multi-cancer early detection testing (NCT06870916) is an observational study sponsored by M.D. Anderson Cancer Center. It aims to develop a participant educational aid to support informed decisions about multi-cancer early detection tests.

The registry record, read on 29 October 2026, gives its status as suspended, with an estimated 150 participants, a start on 7 March 2025 and primary completion expected on 1 January 2027.

## Fields

- Kind: Trial
- Last checked: 2026-10-29
- Registry id: NCT06870916
- Phase: observational
- Setting: Adults at MD Anderson Cancer Center taking part in developing an educational aid about multi-cancer blood tests
- Sponsor: M.D. Anderson Cancer Center
- Enrolled: 150

## Sources

- ClinicalTrials.gov NCT06870916: https://clinicaltrials.gov/study/NCT06870916

## Connected records

- ideas: [A mandatory decision aid before any multi-cancer blood test](https://onco.cc/ideas/idea-prev-mced-pretest-decision-aid/)
- fronts: [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- institutions: [MD Anderson Cancer Center](https://onco.cc/institutions/md-anderson/)

---
JSON: https://onco.cc/api/v1/entities/mdacc-mced-decision-aid.json